Mylan Accused Of 'Whopping Misstatements' In Doryx Row
Warner Chilcott PLC on Wednesday ripped Mylan Pharmaceuticals Inc.'s bid to revive a suit accusing Warner of tweaking the formula of its acne medication Doryx in order to block generic competition,...To view the full article, register now.
Already a subscriber? Click here to view full article